{"id":1361,"date":"2024-06-12T08:24:59","date_gmt":"2024-06-12T08:24:59","guid":{"rendered":"https:\/\/www.gide-regimbeau-patentlitigation.com\/?p=1361"},"modified":"2024-06-13T15:48:16","modified_gmt":"2024-06-13T15:48:16","slug":"gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen","status":"publish","type":"post","link":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/","title":{"rendered":"Gide x Regimbeau \u2013 Patent Litigation : tenue de la conf\u00e9rence de mise en \u00e9tat dans l’affaire Meril Italy S.r.l. \/ Edwards Lifesciences Corporation devant le Juge-rapporteur de la Division Centrale de Paris (JUB)"},"content":{"rendered":"\n

Le 18 mars 2024, en application de la R\u00e8gle 105 du R\u00e8glement de Proc\u00e9dure de la Juridiction Unifi\u00e9e du Brevet (RoP), le Juge-rapporteur de la Division Centrale de Paris a tenu la conf\u00e9rence de mise en \u00e9tat de l’action en nullit\u00e9 introduite par la soci\u00e9t\u00e9 Meril Italy S.r.l., repr\u00e9sent\u00e9e par Gide x Regimbeau \u2013 Patent Litigation, \u00e0 l’encontre du brevet EP 3 646 825 (EP 825) d\u00e9tenu par la soci\u00e9t\u00e9 Edwards Lifesciences Corporation.<\/p>\n\n\n\n

Durant cette conf\u00e9rence de mise en \u00e9tat, tenue par vid\u00e9oconf\u00e9rence et \u00e0 laquelle \u00e9tait exceptionnellement invit\u00e9e la Chambre d\u00e9sign\u00e9e (avec l’accord pr\u00e9alable des parties donn\u00e9 au d\u00e9but de la conf\u00e9rence), le Juge-rapporteur a successivement r\u00e9sum\u00e9 les \u00e9tapes de la proc\u00e9dure \u00e0 date, identifi\u00e9 les questions principales du litige et demand\u00e9 aux parties de clarifier leur position \u00e0 leur sujet.<\/p>\n\n\n\n

Les \u00e9changes entre les repr\u00e9sentants des parties et le Juge-rapporteur ont notamment concern\u00e9 :<\/p>\n\n\n\n

    \n
  1. Le fait de savoir si la soci\u00e9t\u00e9 Edwards Lifesciences Corporation \u00e9tait dispos\u00e9e \u00e0 r\u00e9duire ou modifier le nombre de jeux alternatifs de revendications (requ\u00eates subsidiaires) telles qu’incluses dans sa demande de modification du brevet EP 825 d\u00e9pos\u00e9e le 16 octobre 2023 en application des R\u00e8gles 49 et 30 RoP, et si la soci\u00e9t\u00e9 Meril Italy S.r.l. \u00e9tait dispos\u00e9e \u00e0 accepter cette r\u00e9duction ou modification.

    Pour m\u00e9moire, la soci\u00e9t\u00e9 Meril Italy S.r.l. a soulev\u00e9 au cours de la proc\u00e9dure \u00e9crite la non-admissibilit\u00e9 des 84 requ\u00eates subsidiaires d\u00e9pos\u00e9es par la soci\u00e9t\u00e9 Edwards Lifesciences Corporation car elle consid\u00e8re que celles-ci ignorent notamment les exigences de contenu et de structure list\u00e9es aux R\u00e8gles 50\u00a72 et 30\u00a71 RoP et, plus particuli\u00e8rement, qu’elles ne sont pas “raisonnables eu \u00e9gard aux circonstances de l’affaire<\/em>” conform\u00e9ment \u00e0 la R\u00e8gle 30\u00a71, (b), RoP.

    Si les parties n’ont pas trouv\u00e9 d’accord \u00e0 ce sujet, elles ont \u00e9t\u00e9 invit\u00e9es par le Juge-rapporteur \u00e0 explorer les possibilit\u00e9s de r\u00e9gler cette question \u00e0 l’amiable, en application de la R\u00e8ge 104, (d), RoP, au cours de la proc\u00e9dure de mise en \u00e9tat et aux fins de faciliter l’activit\u00e9 de la Cour visant \u00e0 rendre des d\u00e9cisions rapides et de qualit\u00e9 et d’\u00e9viter d’\u00e9ventuelles activit\u00e9s judiciaires suppl\u00e9mentaires et\/ou un report de l’affaire.

    <\/li>\n\n\n\n
  2. L’interpr\u00e9tation des parties de la lecture de la R\u00e8gle 340 RoP “Connexit\u00e9 et jonction” suivant la demande de la soci\u00e9t\u00e9 Edwards Lifesciences Corporation, formul\u00e9e devant la Division Locale de Munich, \u00e0 ce que la pr\u00e9sente action en nullit\u00e9 devant la Division Centrale de Paris et les demandes reconventionnelles en nullit\u00e9 introduites par les soci\u00e9t\u00e9s Meril Life Sciences Pvt. Ltd. et Meril GmbH \u00e0 l’encontre de EP 825 dans l’action en contrefa\u00e7on initi\u00e9e par la soci\u00e9t\u00e9 Edwards Lifesciences Corporation soient entendues ensemble.

    A ce sujet, le Juge-rapporteur a inform\u00e9 les parties qu’une communication serait \u00e9tablie entre le Panel d\u00e9sign\u00e9 de la Division Centrale de Munich et le Panel d\u00e9sign\u00e9 de la Division Centrale de Paris avant qu’une d\u00e9cision ne soit prise.\u00a0

    <\/li>\n\n\n\n
  3. La d\u00e9cision des parties sur la valeur du litige conform\u00e9ment \u00e0 la R\u00e8gle 370\u00a76 RoP et en application de la R\u00e8gle 104, (i), RoP.

    <\/li>\n\n\n\n
  4. La tenue de discussions pr\u00e9paratoires en vue de l’organisation de l’audience fix\u00e9e au 7 juin 2024 (conditions dans lesquelles les parties peuvent utiliser et pr\u00e9senter des supports de plaidoiries au Panel, dur\u00e9e estim\u00e9e de l’audience, r\u00e9partition du temps allou\u00e9 de plaidoiries), et pour laquelle la soci\u00e9t\u00e9 Meril Italy S.r.l. a demand\u00e9 \u00e0 ce qu’elle se d\u00e9roule dans les locaux du Tribunal de commerce de Paris.

    <\/li>\n<\/ol>\n\n\n
    \n
    \"\"
    De gauche \u00e0 droite : Emmanuel Baux-Hendrick (Collaborateur, Gide), Ludivine Meissirel (Collaboratrice, Gide), Luca Chevallier (Counsel, Gide), Rapha\u00eblle Dequir\u00e9-Portier & Emmanuel Larere (Associ\u00e9s, Gide, Repr\u00e9sentant JUB de Meril Italy S.r.l.)<\/em><\/figcaption><\/figure>\n<\/div>\n\n\n

    Cette conf\u00e9rence de mise en \u00e9tat enti\u00e8rement d\u00e9mat\u00e9rialis\u00e9e a permis, sans aucun doute, tant au Juge-rapporteur qu’aux soci\u00e9t\u00e9s Meril Italy S.r.l. et Edwards Lifesciences Corporation d’\u00e9claircir certains points de la proc\u00e9dure avant l’audience.<\/p>\n\n\n\n

    Le 22 mars 2024, une ordonnance a \u00e9t\u00e9 rendue par le Juge-rapporteur de la Division Centrale de Paris pour r\u00e9sumer les discussions tenues et les d\u00e9cisions prises lors de la conf\u00e9rence de mise en \u00e9tat.<\/p>\n","protected":false},"excerpt":{"rendered":"

    Le 18 mars 2024, en application de la R\u00e8gle 105 du R\u00e8glement de Proc\u00e9dure de la Juridiction Unifi\u00e9e du Brevet (RoP), le Juge-rapporteur de la Division Centrale de Paris a tenu la conf\u00e9rence de mise en \u00e9tat de l’action en nullit\u00e9 introduite par la soci\u00e9t\u00e9 Meril Italy S.r.l., repr\u00e9sent\u00e9e par Gide x Regimbeau \u2013 Patent […]<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[14],"tags":[],"class_list":["post-1361","post","type-post","status-publish","format-standard","hentry","category-communiques"],"acf":[],"yoast_head":"\nGide x Regimbeau \u2013 Patent Litigation : tenue de la conf\u00e9rence de mise en \u00e9tat dans l'affaire Meril Italy S.r.l. \/ Edwards Lifesciences Corporation devant le Juge-rapporteur de la Division Centrale de Paris (JUB) - Gide X Regimbeau<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gide x Regimbeau \u2013 Patent Litigation : tenue de la conf\u00e9rence de mise en \u00e9tat dans l'affaire Meril Italy S.r.l. \/ Edwards Lifesciences Corporation devant le Juge-rapporteur de la Division Centrale de Paris (JUB) - Gide X Regimbeau\" \/>\n<meta property=\"og:description\" content=\"Le 18 mars 2024, en application de la R\u00e8gle 105 du R\u00e8glement de Proc\u00e9dure de la Juridiction Unifi\u00e9e du Brevet (RoP), le Juge-rapporteur de la Division Centrale de Paris a tenu la conf\u00e9rence de mise en \u00e9tat de l’action en nullit\u00e9 introduite par la soci\u00e9t\u00e9 Meril Italy S.r.l., repr\u00e9sent\u00e9e par Gide x Regimbeau \u2013 Patent […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/\" \/>\n<meta property=\"og:site_name\" content=\"Gide X Regimbeau\" \/>\n<meta property=\"article:published_time\" content=\"2024-06-12T08:24:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-06-13T15:48:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.gide-regimbeau-patentlitigation.com\/wp-content\/uploads\/2024\/06\/Gide-x-Regimbeau-2024-1-1024x615.png\" \/>\n<meta name=\"author\" content=\"Gide x Regimbeau\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gide x Regimbeau\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\\\/\"},\"author\":{\"name\":\"Gide x Regimbeau\",\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/#\\\/schema\\\/person\\\/f4e32bdaa870b360d16fd75ae85f2f1d\"},\"headline\":\"Gide x Regimbeau \u2013 Patent Litigation : tenue de la conf\u00e9rence de mise en \u00e9tat dans l’affaire Meril Italy S.r.l. \\\/ Edwards Lifesciences Corporation devant le Juge-rapporteur de la Division Centrale de Paris (JUB)\",\"datePublished\":\"2024-06-12T08:24:59+00:00\",\"dateModified\":\"2024-06-13T15:48:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\\\/\"},\"wordCount\":782,\"commentCount\":0,\"image\":{\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Gide-x-Regimbeau-2024-1-1024x615.png\",\"articleSection\":[\"Communiqu\u00e9s\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\\\/\",\"url\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\\\/\",\"name\":\"Gide x Regimbeau \u2013 Patent Litigation : tenue de la conf\u00e9rence de mise en \u00e9tat dans l'affaire Meril Italy S.r.l. \\\/ Edwards Lifesciences Corporation devant le Juge-rapporteur de la Division Centrale de Paris (JUB) - Gide X Regimbeau\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Gide-x-Regimbeau-2024-1-1024x615.png\",\"datePublished\":\"2024-06-12T08:24:59+00:00\",\"dateModified\":\"2024-06-13T15:48:16+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/#\\\/schema\\\/person\\\/f4e32bdaa870b360d16fd75ae85f2f1d\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\\\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Gide-x-Regimbeau-2024-1-1024x615.png\",\"contentUrl\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/wp-content\\\/uploads\\\/2024\\\/06\\\/Gide-x-Regimbeau-2024-1-1024x615.png\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/fr\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gide x Regimbeau \u2013 Patent Litigation : tenue de la conf\u00e9rence de mise en \u00e9tat dans l’affaire Meril Italy S.r.l. \\\/ Edwards Lifesciences Corporation devant le Juge-rapporteur de la Division Centrale de Paris (JUB)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/#website\",\"url\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/\",\"name\":\"Gide X Regimbeau\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.gide-regimbeau-patentlitigation.com\\\/#\\\/schema\\\/person\\\/f4e32bdaa870b360d16fd75ae85f2f1d\",\"name\":\"Gide x Regimbeau\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be57961f463a0633bf393525c8925b61935ff71e0f63c5efb92e0e5ce18e9c95?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be57961f463a0633bf393525c8925b61935ff71e0f63c5efb92e0e5ce18e9c95?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/be57961f463a0633bf393525c8925b61935ff71e0f63c5efb92e0e5ce18e9c95?s=96&d=mm&r=g\",\"caption\":\"Gide x Regimbeau\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gide x Regimbeau \u2013 Patent Litigation : tenue de la conf\u00e9rence de mise en \u00e9tat dans l'affaire Meril Italy S.r.l. \/ Edwards Lifesciences Corporation devant le Juge-rapporteur de la Division Centrale de Paris (JUB) - Gide X Regimbeau","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/","og_locale":"fr_FR","og_type":"article","og_title":"Gide x Regimbeau \u2013 Patent Litigation : tenue de la conf\u00e9rence de mise en \u00e9tat dans l'affaire Meril Italy S.r.l. \/ Edwards Lifesciences Corporation devant le Juge-rapporteur de la Division Centrale de Paris (JUB) - Gide X Regimbeau","og_description":"Le 18 mars 2024, en application de la R\u00e8gle 105 du R\u00e8glement de Proc\u00e9dure de la Juridiction Unifi\u00e9e du Brevet (RoP), le Juge-rapporteur de la Division Centrale de Paris a tenu la conf\u00e9rence de mise en \u00e9tat de l’action en nullit\u00e9 introduite par la soci\u00e9t\u00e9 Meril Italy S.r.l., repr\u00e9sent\u00e9e par Gide x Regimbeau \u2013 Patent […]","og_url":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/","og_site_name":"Gide X Regimbeau","article_published_time":"2024-06-12T08:24:59+00:00","article_modified_time":"2024-06-13T15:48:16+00:00","og_image":[{"url":"https:\/\/www.gide-regimbeau-patentlitigation.com\/wp-content\/uploads\/2024\/06\/Gide-x-Regimbeau-2024-1-1024x615.png","type":"","width":"","height":""}],"author":"Gide x Regimbeau","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"Gide x Regimbeau","Dur\u00e9e de lecture estim\u00e9e":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/#article","isPartOf":{"@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/"},"author":{"name":"Gide x Regimbeau","@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/#\/schema\/person\/f4e32bdaa870b360d16fd75ae85f2f1d"},"headline":"Gide x Regimbeau \u2013 Patent Litigation : tenue de la conf\u00e9rence de mise en \u00e9tat dans l’affaire Meril Italy S.r.l. \/ Edwards Lifesciences Corporation devant le Juge-rapporteur de la Division Centrale de Paris (JUB)","datePublished":"2024-06-12T08:24:59+00:00","dateModified":"2024-06-13T15:48:16+00:00","mainEntityOfPage":{"@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/"},"wordCount":782,"commentCount":0,"image":{"@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/#primaryimage"},"thumbnailUrl":"https:\/\/www.gide-regimbeau-patentlitigation.com\/wp-content\/uploads\/2024\/06\/Gide-x-Regimbeau-2024-1-1024x615.png","articleSection":["Communiqu\u00e9s"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/","url":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/","name":"Gide x Regimbeau \u2013 Patent Litigation : tenue de la conf\u00e9rence de mise en \u00e9tat dans l'affaire Meril Italy S.r.l. \/ Edwards Lifesciences Corporation devant le Juge-rapporteur de la Division Centrale de Paris (JUB) - Gide X Regimbeau","isPartOf":{"@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/#primaryimage"},"image":{"@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/#primaryimage"},"thumbnailUrl":"https:\/\/www.gide-regimbeau-patentlitigation.com\/wp-content\/uploads\/2024\/06\/Gide-x-Regimbeau-2024-1-1024x615.png","datePublished":"2024-06-12T08:24:59+00:00","dateModified":"2024-06-13T15:48:16+00:00","author":{"@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/#\/schema\/person\/f4e32bdaa870b360d16fd75ae85f2f1d"},"breadcrumb":{"@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/#primaryimage","url":"https:\/\/www.gide-regimbeau-patentlitigation.com\/wp-content\/uploads\/2024\/06\/Gide-x-Regimbeau-2024-1-1024x615.png","contentUrl":"https:\/\/www.gide-regimbeau-patentlitigation.com\/wp-content\/uploads\/2024\/06\/Gide-x-Regimbeau-2024-1-1024x615.png"},{"@type":"BreadcrumbList","@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/gide-x-regimbeau-patent-litigation-tenue-de-la-conference-de-mise-en-etat-dans-laffaire-meril-italy-s-r-l-edwards-lifesciences-corporation-devant-le-juge-rapporteur-de-la-division-cen\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Gide x Regimbeau \u2013 Patent Litigation : tenue de la conf\u00e9rence de mise en \u00e9tat dans l’affaire Meril Italy S.r.l. \/ Edwards Lifesciences Corporation devant le Juge-rapporteur de la Division Centrale de Paris (JUB)"}]},{"@type":"WebSite","@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/#website","url":"https:\/\/www.gide-regimbeau-patentlitigation.com\/","name":"Gide X Regimbeau","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.gide-regimbeau-patentlitigation.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.gide-regimbeau-patentlitigation.com\/#\/schema\/person\/f4e32bdaa870b360d16fd75ae85f2f1d","name":"Gide x Regimbeau","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/secure.gravatar.com\/avatar\/be57961f463a0633bf393525c8925b61935ff71e0f63c5efb92e0e5ce18e9c95?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/be57961f463a0633bf393525c8925b61935ff71e0f63c5efb92e0e5ce18e9c95?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/be57961f463a0633bf393525c8925b61935ff71e0f63c5efb92e0e5ce18e9c95?s=96&d=mm&r=g","caption":"Gide x Regimbeau"}}]}},"_links":{"self":[{"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/posts\/1361","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/comments?post=1361"}],"version-history":[{"count":2,"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/posts\/1361\/revisions"}],"predecessor-version":[{"id":1366,"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/posts\/1361\/revisions\/1366"}],"wp:attachment":[{"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/media?parent=1361"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/categories?post=1361"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.gide-regimbeau-patentlitigation.com\/fr\/wp-json\/wp\/v2\/tags?post=1361"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}